New ‘hit-and-run’ gene editing tool temporarily rewrites genetics to treat cancer and HIV – GeekWire
Posted: September 6, 2017 at 2:44 am
Nanoparticles (orange) deliver temporary gene therapy to immune cells (blue) to give them disease-fighting tools. (Fred Hutch Illustration / Kimberly Carney)
CAR T immunotherapies are all the rage in the medical community, reprogramming a patients immune system to fight cancer. For some patients, theyve produced near-miraculous recoveries, and they could be a huge breakthrough in cancer treatment.
The business community is taking note as well: Kite Pharma, a biotech company developing these therapies, announced a deal to be acquired for $11.9 billion on Monday, sending stock prices of Seattle immunotherapy developer Juno Therapeuticsskyrocketing.
But there are still giant pitfalls to using the therapies on a large scale because they are incredibly complex and expensive to produce. Researchers from Seattles Fred Hutchinson Cancer Research Center are taking the problem head-on with new hit-and-run gene editing technology.
In a study published Wednesday in the journal Nature Communications, researchers led by Dr.Matthias Stephan reported they have developed a nanoparticle delivery system that can temporarily alter cells so they are able to fight cancer and other diseases.
The best part? The treatment is a powder that just needs to be mixed with water to activate and even better, it could be an essential breakthrough in making cutting-edge medical technology affordable for patients.
Stephan told GeekWire in a previous piece on the technology that his goal is to make immunotherapy so easy to access that it replaces chemotherapy as the front-line treatment for cancer.
What I envision is like the Walgreens flu shot scenario, or you go to your doctor and you get hepatitis B shot, he said at the time. You go there every Friday, and thats it.
We realized in order to outcompete chemotherapy, we have to design something that is at least as affordable and can be manufactured at large scale by one biotech company and shipped out to local infusion centers, Stephan said. At the moment, CAR T cell therapies must be made individually for each patient in specialized labs.
Heres how the new tech works: The nanoparticles designed by Stephan and his team act like shipping containers for bundles of mRNA, the molecules that tell cells how to build disease-fighting proteins. The nanoparticles also have molecules attached to the outside to help them find the right kind of cells, like a shipping label on a package.
When the mRNA is delivered to the cell, it prompts the cell to grow disease-fighting features, like the chimeric antigen receptor in CAR T cells that help them identify and kill cancer.Researchers said the technology could potentially be used to develop treatments for HIV, diabetes and other immune-related diseases.
In the short run, the tech could help researchers discover new treatments and therapies in the lab. It could one day be used in hospitals and clinics around the world, but will first need to undergo extensive clinical trials to ensure the tech is effective and safe to use in humans.
Read more from the original source:
New 'hit-and-run' gene editing tool temporarily rewrites genetics to treat cancer and HIV - GeekWire
- Oncotype DX: Genomic Test to Inform Breast Cancer Treatment - September 29th, 2018
- what is gene therapy? - Bluebird Bio - May 24th, 2018
- Gene therapy - Doctor.ndtv.com - May 18th, 2018
- South Bend man a 'walking miracle' after cancer treatment breakthrough - South Bend Tribune - September 6th, 2017
- UTSA Presidential Lecture featuring Leonard Pinchuk - UTSA Today - September 6th, 2017
- Why the federal government urgently needs to fund more cancer research - Los Angeles Times - September 6th, 2017
- First gene therapy to treat cancer gets FDA approval; UM only Michigan hospital to use it - Detroit Free Press - September 1st, 2017
- Man describes new FDA-approved gene therapy for leukemia that changed his life - fox4kc.com - September 1st, 2017
- Gilead is buying Kite Pharma, a cancer-fighting Santa Monica biotech firm, for $11.9 billion - Los Angeles Times - August 30th, 2017
- Stanford Center Hopes to Take Stem Cell and Gene Therapies to a New Level - Sickle Cell Anemia News - August 25th, 2017
- Baltimore 5K Aims to Raise Awareness about Sickle Cell Disease - Afro American - August 25th, 2017
- Doctor on new cancer treatment: 'genetically engineered, tumor-killing factory' - The Business Journal - August 23rd, 2017
- New 3D-drug screening aims to ease economic burden of rare muscle diseases - Medical Xpress - August 22nd, 2017
- DHK - Representative Chris Walsh, 66, non-Hodgkin lymphoma (a white blood cell cancer), Framingham, with Dr ... - WEEI.com - August 21st, 2017
- Life Lessons: Next generation testing - WFMZ Allentown - August 21st, 2017
- Potential therapy for eye condition - WTAJ - August 21st, 2017
- Exclusive interview with Discovery's First in Human sickle cell ... - Monsters and Critics.com - August 18th, 2017
- Families with kids with Jordan's Syndrome meet for study to learn more about rare gene mutation - FOX 5 DC - August 11th, 2017
- Springfield Mom Works to Raise Awareness after Son Diagnosed with Rare Genetic Disorder - KRCU - August 11th, 2017
- Cancer's Newest Miracle Cure - TIME - August 10th, 2017
- Springfield Mom Works to Raise Awareness after Son Diagnosed with Rare Genetic Disorder - KSMU Radio - August 9th, 2017
- New Gene Therapy for Vision Loss Proven Safe in Humans ... - August 8th, 2017
- Indian-origin doctor helps gene editing of human embryos - Times of India - August 7th, 2017
- WBZ-TV Riders Take On Pan-Mass Challenge - CBS Boston / WBZ - August 7th, 2017
- Gene editing breakthrough: Perspective from a geneticist and a pastor - WTSP 10 News - August 7th, 2017
- Scientists successfully doctor human embroyo - Examiner Enterprise - August 7th, 2017
- New cancer therapy in clinical trial at Nebraska Medical Center has ... - Omaha World-Herald - August 1st, 2017
- Ocean Springs parents fight to save 3-year-old daughter from fatal genetic condition - WGNO - July 31st, 2017
- US doctor who wanted to treat Charlie Gard had 'financial interest' says Great Ormond Street - Metro - July 31st, 2017
- Baby Charlie remains on life support as parents fight doctors for experimental treatment - CBC.ca - July 13th, 2017
- Novel cancer treatment wins endorsement of FDA advisers - Washington Post - July 13th, 2017
- High-tech solutions top the list in the fight against eye disease - Engadget - July 12th, 2017
- 'Prehab' therapy helps cancer patients prepare for treatment - KTBS - July 12th, 2017
- Tumor gene testing urged to tell if drug targets your cancer - The ... - The Mainichi - July 10th, 2017
- Charlie Gard: Medical experts weigh in on case of terminally-ill baby - The Independent - July 10th, 2017
- Tumor gene testing urged to tell if drug targets your cancer | KRQE ... - KRQE News 13 - July 8th, 2017
- Tumor gene testing urged to tell if drug targets your cancer - ABC News - July 7th, 2017
- Cancer treatment is swiftly moving toward individualized molecular and genetic tools that Sparrow Cancer Center's ... - City Pulse - July 7th, 2017
- What to Know About Charlie Gard, the Terminally Ill Baby Trump Wants to Help - TIME - July 4th, 2017
- Why the super-rich are ploughing billions into the booming 'immortality industry' - Evening Standard - July 1st, 2017
- Worlds Leading Biomarkers Congress | CPD Points ... - September 22nd, 2016
- Breast Cancer Risk Factors: Genetics - August 24th, 2016
- Local Doctor Leads Study Of Gene Therapy Treatment For ... - March 19th, 2016
- Dr Rajiv Desai Blog Archive GENE THERAPY - August 23rd, 2015
- Gene Therapy | Doctor | Patient - June 9th, 2015
- Gene Therapy | Doctor | Patient.co.uk - May 23rd, 2015